Skip to main content
Frontiers in Medicine logoLink to Frontiers in Medicine
. 2025 Aug 18;12:1677216. doi: 10.3389/fmed.2025.1677216

Correction: Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—A clinical pilot study

Frontiers Production Office1,*
PMCID: PMC12401010  PMID: 40901516

In the Introduction section, paragraph 7, the last sentence incorrectly stated:

However, although specific functional autoantibodies were elevated during acute COVID-19 infection (14), the number and magnitude of autoreactivities to the exoproteome were similar in individuals with or without LC (17), suggesting that the pattern of functional autoantibody responses, rather than single pathogenic autoantibodies, may be relevant.

The correct sentence should read:

However, although specific functional autoantibodies were elevated during acute COVID-19 infection (14), the number and magnitude of autoreactivities to the exoproteome were similar in individuals with or without ME/CFS (17), suggesting that the pattern of functional autoantibody responses, rather than single pathogenic autoantibodies, may be relevant.

The original version of this article has been updated.


Articles from Frontiers in Medicine are provided here courtesy of Frontiers Media SA

RESOURCES